{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-002715","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.530503+00:00","generated_at":"2026-06-06T13:26:19.768669+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Avalo regains Nasdaq minimum bid compliance; subject to 1-year panel monitor","bullets":["Received Nasdaq letter January 30, 2024 confirming compliance with $1.00 bid price rule.","Reverse stock split on December 28, 2023 brought stock above $1.00 since December 29, 2023.","Mandatory panel monitor for one year from January 30, 2024; no cure period if noncompliant again.","If noncompliant during monitor, Nasdaq will issue delist letter; company can request hearing.","Failure to satisfy panel could result in delisting from Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-002715","json":"https://secwatch.observer/filing/0001628280-24-002715.json","markdown":"https://secwatch.observer/filing/0001628280-24-002715.md","text":"https://secwatch.observer/filing/0001628280-24-002715.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828024002715/0001628280-24-002715-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828024002715/avtx-20240130.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T13:26:19.768669+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}